Geodon, also known as ziprasidone, is a medication used to treat schizophrenia. The drug was approved by the Food and Drug Administration (FDA) in February 2001 and is manufactured by Pfizer Pharmaceuticals.
The FDA approved Geodon in February of 2001 for the treatment of schizophrenia and added approval for the treatment of acute bipolar mania in 2004. Marketed by Pfizer, use of the drug is associated with hyperglycemia, diabetes mellitus, and even more serious heart and neurological conditions.
In August 2004, the FDA forced Pfizer to place warnings on Geodon for hyperglycemia and diabetes, but to this day Pfizer refuses to place a warning for the heart and neurological conditions. These conditions include torsade de points, a form of ventricular tachycardia, and Tardive Dyskinesia, a disease affecting the brain which causes involuntary movements. Since 2001, the FDA received multiple reports of heart beat abnormalities and unexplained deaths among Geodon users.
FREE DEFECTIVE DRUG RECALL Case Evaluation
The Drug Recall Help Center is a FREE consumer service and part of the Legal Help Center Network. Each month, more than 100,000 consumers visit our Legal Help Centers seeking to find legal help to evaluate their cases.
| Disclaimer
| Privacy Policy
| SITEMAP
